Protalix BioTherapeutics, Inc. (AMEX:PLX) Q2 2023 Earnings Call Transcript August 7, 2023
Operator: Good morning, ladies and gentlemen and welcome to the Protalix BioTherapeutics Conference for Second Quarter 2023 Financial Business Results. As a reminder, this conference is being recorded. I will now turn the conference over to our host, Mr. Chuck Padala with LifeSci Advisors, Investor Relations for Protalix. Thank you, you may begin the conference.
Charles Padala: Thank you, operator and...
